News
Complex Pandemic Accord negotiations have been underway since 2021, with 13 formal meetings and numerous informal sessions.
Pfizer Inc.'s stock is trading at $22 with an 8% dividend yield, driven by market fears over losing vaccine revenues. Read ...
A review of 600 US patients treated for suspected sepsis found 31.5% most likely didn't have a bacterial infection, while ...
Novavax (NasdaqGS:NVAX) recently announced promising preliminary results from the SHIELD-Utah study, which highlighted fewer and less severe reactogenicity symptoms for its COVID-19 Vaccine, ...
The advisory committee, which met Tuesday for the first time since Robert F. Kennedy Jr. was sworn in as health secretary, ...
An advisory panel on vaccines meets, carefully, in the shadow of a health secretary who has often criticized it.
Duck Creek Technologies, the global intelligent solutions provider defining the future of property and casualty (P&C) and general insurance, has announced the appointment of General Daniel Hokanson, ...
As in previous studies, the SHIELD study found health care workers who received the Novavax vaccine reported significantly ...
by Timothy McQuiston, Vermont Business Magazine The Vermont Department of Health reported last week that the number of COVID-19 hospitalizations remains low, at under 5 after a spike in January.
Novavax (NVAX) announced preliminary results from the SHIELD-Utah study that showed Novavax’s COVID-19 Vaccine, Adjuvanted 2024-2025 Formula ...
Mass firings at the U.S. Food and Drug Administration are particularly risky for small- and mid-cap biotech companies that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results